We are live on
!
Find out more
TRCT
Tower Research Capital (TRC) Portfolio holdings
AUM
$4.08B
1-Year Est. Return
58.77%
This Fund
S&P 500
This Quarter
Est. Return
+10.48%
1 Year Est. Return
+58.77%
3 Year Est. Return
+143.94%
5 Year Est. Return
+167.17%
10 Year Est. Return
+536.06%
AUM
$3.62B
AUM Growth
-$84.4M
(-2.3%)
Cap. Flow
-$358M
Cap. Flow
% of AUM
-9.89%
Top 10 Holdings %
Top 10 Hldgs %
26.83%
Holding
5,773
New
537
Increased
1,570
Reduced
3,043
Closed
580
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$254M |
| 2 |
iShares 1-3 Year Treasury Bond ETF
SHY
|
+$46.3M |
| 3 |
JPMorgan Ultra-Short Income ETF
JPST
|
+$30.5M |
| 4 |
VBIL
Vanguard 0-3 Month Treasury Bill ETF
VBIL
|
+$29.2M |
| 5 |
iShares 0-3 Month Treasury Bond ETF
SGOV
|
+$24.7M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Apple
AAPL
|
+$46.2M |
| 2 |
Microsoft
MSFT
|
+$46.2M |
| 3 |
Invesco QQQ Trust
QQQ
|
+$40M |
| 4 |
NVIDIA
NVDA
|
+$27.6M |
| 5 |
Palantir
PLTR
|
+$27.6M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 17.33% |
| 2 | Financials | 7.48% |
| 3 | Consumer Discretionary | 6.48% |
| 4 | Healthcare | 6.28% |
| 5 | Communication Services | 6.14% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
3401
Compass Diversified
CODI
$908M
| $18K | ﹤0.01% |
2,721
-11,251
| -81% | -$77.6K |
|
3402
ICL Group
ICL
$7.06B
| $18K | ﹤0.01% |
2,895
+2,454
| +556% | +$15.8K |
|
3403
SI-BONE Inc
SIBN
$852M
| $18K | ﹤0.01% |
1,223
-3,674
| -75% | -$60K |
|
3404
Usana Health Sciences
USNA
$250M
| $18K | ﹤0.01% |
653
-1,745
| -73% | -$53.7K |
|
3405
Dine Brands
DIN
$462M
| $18K | ﹤0.01% |
727
-1,364
| -65% | -$32K |
|
3406
Horizon Bancorp
HBNC
$1.05B
| $17.9K | ﹤0.01% |
1,118
-5,418
| -83% | -$86.8K |
|
|
REFI
3407
Chicago Atlantic Real Estate Finance
REFI
$268M
| $17.9K | ﹤0.01% |
1,399
-579
| -29% | -$7.94K |
|
3408
Conduent
CNDT
$241M
| $17.9K | ﹤0.01% |
6,380
-6,636
| -51% | -$18K |
|
|
DRD
3409
DRDGold
DRD
$2.06B
| $17.9K | ﹤0.01% |
647
+517
| +398% | +$9.25K |
|
3410
Organon & Co
OGN
$3.59B
| $17.9K | ﹤0.01% |
1,672
+12
| +0.7% | +$118 |
|
3411
Cricut
CRCT
$1.23B
| $17.8K | ﹤0.01% |
2,834
-2,983
| -51% | -$17.5K |
|
3412
Neonode
NEON
$16.6M
| $17.8K | ﹤0.01% |
5,105
+4,068
| +392% | +$75K |
|
|
CHMI
3413
Cherry Hill Mortgage Investment Corp
CHMI
$107M
| $17.8K | ﹤0.01% |
+7,452
| New | +$20.6K |
|
3414
Under Armour Class C
UA
$2.2B
| $17.8K | ﹤0.01% |
3,686
-1,540
| -29% | -$8.61K |
|
3415
Nature's Sunshine
NATR
$273M
| $17.8K | ﹤0.01% |
1,147
-600
| -34% | -$9.59K |
|
3416
Organogenesis Holdings
ORGO
$226M
| $17.7K | ﹤0.01% |
4,202
-19,453
| -82% | -$90.4K |
|
|
MRUS
3417
DELISTED
Merus
MRUS
| $17.7K | ﹤0.01% |
188
-228
| -55% | -$14.9K |
|
3418
Haverty Furniture Companies
HVT
$441M
| $17.7K | ﹤0.01% |
807
-3,486
| -81% | -$77.5K |
|
3419
Fortress Biotech
FBIO
$91.4M
| $17.7K | ﹤0.01% |
4,783
+3,879
| +429% | +$9.81K |
|
3420
American Realty Investors
ARL
$243M
| $17.6K | ﹤0.01% |
1,055
-341
| -24% | -$4.99K |
|
3421
JELD-WEN Holding
JELD
$164M
| $17.6K | ﹤0.01% |
3,589
-5,628
| -61% | -$30.1K |
|
3422
EyePoint Inc
EYPT
$1.16B
| $17.6K | ﹤0.01% |
1,235
-7,465
| -86% | -$85.9K |
|
3423
Fulcrum Therapeutics
FULC
$283M
| $17.6K | ﹤0.01% |
1,910
-4,467
| -70% | -$32.3K |
|
3424
Colony Bankcorp
CBAN
$467M
| $17.6K | ﹤0.01% |
1,033
-927
| -47% | -$15.8K |
|
|
SCPH
3425
DELISTED
scPharmaceuticals
SCPH
| $17.5K | ﹤0.01% |
3,086
-6,238
| -67% | -$31.9K |
|
Similar funds
CA
ICP
AP
BWA
JSW
SP
GCM
ZP
Tower Research Capital (TRC)'s Q3 2025 Portfolio in Review
As of Q3 2025, Tower Research Capital (TRC) held 5,773 positions worth $3.62B, down 2.3% from $3.71B the previous quarter. Its ten largest holdings account for 27% of the portfolio.
Tower Research Capital (TRC) withdrew a net $358M in Q3 2025, closing 580 positions and reducing 3,043 holdings. Its most notable exit was Vanguard S&P 500 ETF, an estimated $23.6M position sold in full.
By sector, the portfolio is most concentrated in Technology at 17% of assets, down from 20% a quarter earlier, followed by Financials and Consumer Discretionary.
Against the trend, Tower Research Capital (TRC) opened a new position in JPMorgan Ultra-Short Income ETF worth $30.6M.
- Tower Research Capital (TRC)'s largest Q3 2025 buy was JPMorgan Ultra-Short Income ETF: 603,010 shares worth $30.6M.
- Tower Research Capital (TRC) added most to State Street SPDR S&P 500 ETF Trust in Q3 2025, an estimated $254M increase.
- Tower Research Capital (TRC)'s biggest Q3 2025 reduction was Apple, cutting an estimated $46.2M.
- Tower Research Capital (TRC) fully exited Vanguard S&P 500 ETF in Q3 2025, selling an estimated $23.6M.
- Tower Research Capital (TRC)'s ten largest holdings make up 27% of its $3.62B portfolio in Q3 2025.
- Tower Research Capital (TRC) opened 537 new positions and closed 580 in Q3 2025.
- Tower Research Capital (TRC)'s portfolio value fell 2.3% quarter-over-quarter to $3.62B.
Based on Tower Research Capital (TRC)'s 13F filing for Q3 2025, filed 14 Nov 2025.